BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

ProjectUpdated on 3 September 2026

Hong Kong Pioneering Radiopharmaceutical Project

Corporate development at ZERO Biotech Co. Ltd

China (Hong Kong)

About

As a member of Hong Kong Science Park, we are a leading radiopharmaceutical company in Hong Kong, strategically located in the city's nationally recognized biotechnology hub. Leveraging Hong Kong's unique position as a gateway between mainland China and the global market, ZERO Biotech is well positioned to accelerate innovation and deliver cutting-edge NM products to patients worldwide.

Project Location

  • China (Hong Kong)

Project Format

  • Private Project

Go Global Project

  • Yes

ESG (Environmental, Social, and Governance)

  • Yes

Project Stage

  • Operations

Main Project Sector

  • Technology

Total Project Value

  • 50,000,001 USD or above

Investment Capital Required

  • 10,000,001 to 25,000,000 USD

Interested Format of Cooperation

  • Direct Equity Investment

Type(s) of Last Financing Round of the project (if Applicable)

  • Equity (private)

Main Service(s) Required

  • Professional Services

Similar opportunities